Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 22815883)


Retention in a NGO supported antiretroviral program in the Democratic Republic of Congo.

Koole O, Kalenga L, Kiumbu M, Menten J, Ryder RW, Mukumbi H, Colebunders R.

PLoS One. 2012;7(7):e40971. doi: 10.1371/journal.pone.0040971. Epub 2012 Jul 17.


Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia.

Koole O, Tsui S, Wabwire-Mangen F, Kwesigabo G, Menten J, Mulenga M, Auld A, Agolory S, Mukadi YD, Colebunders R, Bangsberg DR, van Praag E, Torpey K, Williams S, Kaplan J, Zee A, Denison J.

Trop Med Int Health. 2014 Dec;19(12):1397-410. doi: 10.1111/tmi.12386. Epub 2014 Sep 17.


Antiretroviral treatment program retention among HIV-infected children in the Democratic Republic of Congo.

Ditekemena J, Luhata C, Bonane W, Kiumbu M, Tshefu A, Colebunders R, Koole O.

PLoS One. 2014 Dec 26;9(12):e113877. doi: 10.1371/journal.pone.0113877. eCollection 2014.


Outcomes of antiretroviral therapy over a 10-year period of expansion: a multicohort analysis of African and Asian HIV programs.

Grimsrud A, Balkan S, Casas EC, Lujan J, Van Cutsem G, Poulet E, Myer L, Pujades-Rodriguez M.

J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):e55-66. doi: 10.1097/QAI.0000000000000268.


Patient retention, clinical outcomes and attrition-associated factors of HIV-infected patients enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007-2010.

Mutasa-Apollo T, Shiraishi RW, Takarinda KC, Dzangare J, Mugurungi O, Murungu J, Abdul-Quader A, Woodfill CJ.

PLoS One. 2014 Jan 29;9(1):e86305. doi: 10.1371/journal.pone.0086305. eCollection 2014.


The pattern of attrition from an antiretroviral treatment program in Nigeria.

Odafe S, Torpey K, Khamofu H, Ogbanufe O, Oladele EA, Kuti O, Adedokun O, Badru T, Okechukwu E, Chabikuli O.

PLoS One. 2012;7(12):e51254. doi: 10.1371/journal.pone.0051254. Epub 2012 Dec 13.


Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa.

KIDS-ART-LINC Collaboration.

J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):523-31. doi: 10.1097/QAI.0b013e31818aadce.


Retention in an antiretroviral therapy programme during an era of decreasing drug cost in Limbe, Cameroon.

Mosoko JJ, Akam W, Weidle PJ, Brooks JT, Aweh AJ, Kinge TN, Pals S, Raghunathan PL.

J Int AIDS Soc. 2011 Jun 16;14:32. doi: 10.1186/1758-2652-14-32.


High retention among HIV-infected children in Rwanda during scale-up and decentralization of HIV care and treatment programs, 2004 to 2010.

Tene G, Lahuerta M, Teasdale C, Mugisha V, Kayonde L, Muhayimpundu R, Nyemazi JP, Vandebriel G, Nsanzimana S, Sahabo R, Twyman P, Abrams EJ.

Pediatr Infect Dis J. 2013 Aug;32(8):e341-7. doi: 10.1097/INF.0b013e31828c2744.


"If I have nothing to eat, I get angry and push the pills bottle away from me": A qualitative study of patient determinants of adherence to antiretroviral therapy in the Democratic Republic of Congo.

Musumari PM, Feldman MD, Techasrivichien T, Wouters E, Ono-Kihara M, Kihara M.

AIDS Care. 2013;25(10):1271-7. doi: 10.1080/09540121.2013.764391. Epub 2013 Feb 6.


High attrition before and after ART initiation among youth (15-24 years of age) enrolled in HIV care.

Lamb MR, Fayorsey R, Nuwagaba-Biribonwoha H, Viola V, Mutabazi V, Alwar T, Casalini C, Elul B.

AIDS. 2014 Feb 20;28(4):559-68. doi: 10.1097/QAD.0000000000000054.


Treatment outcomes from the largest antiretroviral treatment program in Myanmar (Burma): a cohort analysis of retention after scale-up.

Sabapathy K, Ford N, Chan KN, Kyaw MK, Elema R, Smithuis F, Floyd S.

J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):e53-62. doi: 10.1097/QAI.0b013e31824d5689.


Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors.

Charurat M, Oyegunle M, Benjamin R, Habib A, Eze E, Ele P, Ibanga I, Ajayi S, Eng M, Mondal P, Gebi U, Iwu E, Etiebet MA, Abimiku A, Dakum P, Farley J, Blattner W.

PLoS One. 2010 May 11;5(5):e10584. doi: 10.1371/journal.pone.0010584.


Mortality and associated factors after initiation of pediatric antiretroviral treatment in the Democratic Republic of the Congo.

Callens SF, Shabani N, Lusiama J, Lelo P, Kitetele F, Colebunders R, Gizlice Z, Edmonds A, Van Rie A, Behets F; SARA team.

Pediatr Infect Dis J. 2009 Jan;28(1):35-40. doi: 10.1097/INF.0b013e318184eeb9.


Factors associated with late antiretroviral therapy initiation among adults in Mozambique.

Lahuerta M, Lima J, Nuwagaba-Biribonwoha H, Okamura M, Alvim MF, Fernandes R, Assan A, Hoos D, Elul B, El-Sadr WM, Nash D.

PLoS One. 2012;7(5):e37125. doi: 10.1371/journal.pone.0037125. Epub 2012 May 15.


Four-year treatment outcomes of adult patients enrolled in Mozambique's rapidly expanding antiretroviral therapy program.

Auld AF, Mbofana F, Shiraishi RW, Sanchez M, Alfredo C, Nelson LJ, Ellerbrock T.

PLoS One. 2011 Apr 4;6(4):e18453. doi: 10.1371/journal.pone.0018453.


Association of adherence support and outreach services with total attrition, loss to follow-up, and death among ART patients in sub-Saharan Africa.

Lamb MR, El-Sadr WM, Geng E, Nash D.

PLoS One. 2012;7(6):e38443. doi: 10.1371/journal.pone.0038443. Epub 2012 Jun 7.


Similar mortality and reduced loss to follow-up in integrated compared with vertical programs providing antiretroviral treatment in sub-saharan Africa.

Greig J, O'Brien DP, Ford N, Spelman T, Sabapathy K, Shanks L.

J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):e92-8. doi: 10.1097/QAI.0b013e31824206c7.


Mortality among tuberculosis patients in the Democratic Republic of Congo.

Henegar C, Behets F, Vanden Driessche K, Tabala M, Bahati E, Bola V, Van Rie A.

Int J Tuberc Lung Dis. 2012 Sep;16(9):1199-204. doi: 10.5588/ijtld.11.0613.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk